{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:44:56Z","timestamp":1788281096075,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["32661"],"award-info":[{"award-number":["32661"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["KFOC160013"],"award-info":[{"award-number":["KFOC160013"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00198-018-4598-2","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T14:05:41Z","timestamp":1530281141000},"page":"2345-2353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study"],"prefix":"10.1007","volume":"29","author":[{"given":"L.-C.","family":"Desbiens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sidib\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.-V.","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Munger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-P.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-K.","family":"Bisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Marquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Agharazii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6879-9344","authenticated-orcid":false,"given":"F.","family":"Mac-Way","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"key":"4598_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"4598_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","volume":"90","author":"N Carrillo-Lopez","year":"2016","unstructured":"Carrillo-Lopez N, Panizo S, Alonso-Montes C, Roman-Garcia P, Rodriguez I, Martinez-Salgado C, Dusso AS, Naves M, Cannata-Andia JB (2016) Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int 90:77\u201389","journal-title":"Kidney Int"},{"key":"4598_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2015.156","volume":"88","author":"P Evenepoel","year":"2015","unstructured":"Evenepoel P, D'Haese P, Brandenburg V (2015) Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int 88:235\u2013240","journal-title":"Kidney Int"},{"key":"4598_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","volume":"100","author":"S Yamada","year":"2017","unstructured":"Yamada S, Giachelli CM (2017) Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and klotho. Bone 100:87\u201393","journal-title":"Bone"},{"key":"4598_CR5","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2215\/CJN.09470913","volume":"9","author":"HH Malluche","year":"2014","unstructured":"Malluche HH, Davenport DL, Cantor T, Monier-Faugere MC (2014) Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis. Clin J Am Soc Nephrol 9:1254\u20131262","journal-title":"Clin J Am Soc Nephrol"},{"key":"4598_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","volume":"90","author":"S Thambiah","year":"2012","unstructured":"Thambiah S, Roplekar R, Manghat P, Fogelman I, Fraser WD, Goldsmith D, Hampson G (2012) Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness. Calcif Tissue Int 90:473\u2013480","journal-title":"Calcif Tissue Int"},{"key":"4598_CR7","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/ki.2015.194","volume":"88","author":"AR Qureshi","year":"2015","unstructured":"Qureshi AR, Olauson H, Witasp A, Haarhaus M, Brandenburg V, Wernerson A, Lindholm B, S\u00f6derberg M, Wennberg L, Nordfors L, Ripsweden J, Barany P, Stenvinkel P (2015) Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification. Kidney Int 88:1356\u20131364","journal-title":"Kidney Int"},{"key":"4598_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","volume":"132","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Dr\u00fceke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J, Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators* (2015) Cinacalcet, fibroblast growth Factor-23, and cardiovascular disease in hemodialysis: the evaluation of Cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. Circulation 132:27\u201339","journal-title":"Circulation"},{"key":"4598_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bone.2017.02.006","volume":"100","author":"J Kaludjerovic","year":"2017","unstructured":"Kaludjerovic J, Komaba H, Lanske B (2017) Effects of klotho deletion from bone during chronic kidney disease. Bone 100:50\u201355","journal-title":"Bone"},{"key":"4598_CR10","first-page":"599","volume-title":"Kidney Int","author":"H Komaba","year":"2017","unstructured":"Komaba H, Kaludjerovic J, Hu DZ, Nagano K, Amano K, Ide N, Sato T, Densmore MJ, Hanai JI, Olauson H, Bellido T, Larsson TE, Baron R, Lanske B (2017) Klotho expression in osteocytes regulates bone metabolism and controls bone formation. In: Kidney Int, vol 92, pp 599\u2013611"},{"issue":"65","key":"4598_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1161\/HYPERTENSIONAHA.114.04587","volume":"1979","author":"C Fortier","year":"2015","unstructured":"Fortier C, Mac-Way F, Desmeules S, Marquis K, De Serres SA, Lebel M, Boutouyrie P, Agharazii M (2015) Aortic-brachial stiffness mismatch and mortality in dialysis population. Hypertension Dallas Tex 1979(65):378\u2013384","journal-title":"Hypertension Dallas Tex"},{"issue":"62","key":"4598_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1161\/HYPERTENSIONAHA.113.01200","volume":"1979","author":"MS Utescu","year":"2013","unstructured":"Utescu MS, Couture V, Mac-Way F, De Serres SA, Marquis K, Lariviere R, Desmeules S, Lebel M, Boutouyrie P, Agharazii M (2013) Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study. Hypertension Dallas Tex 1979(62):154\u2013160","journal-title":"Hypertension Dallas Tex"},{"key":"4598_CR13","doi-asserted-by":"publisher","first-page":"e0156860","DOI":"10.1371\/journal.pone.0156860","volume":"11","author":"S Tanaka","year":"2016","unstructured":"Tanaka S, Fujita S, Kizawa S, Morita H, Ishizaka N (2016) Association between FGF23, alpha-klotho, and cardiac abnormalities among patients with various chronic kidney disease stages. PLoS One 11:e0156860","journal-title":"PLoS One"},{"key":"4598_CR14","doi-asserted-by":"publisher","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","volume":"297","author":"J Gattineni","year":"2009","unstructured":"Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz R, Mohammadi M, Baum M (2009) FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol 297:F282\u2013F291","journal-title":"Am J Physiol Renal Physiol"},{"key":"4598_CR15","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol : JASN 16:2205\u20132215","journal-title":"J Am Soc Nephrol : JASN"},{"key":"4598_CR16","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1210\/jc.2016-2215","volume":"101","author":"N Souma","year":"2016","unstructured":"Souma N, Isakova T, Lipiszko D, Sacco RL, Elkind MSV, DeRosa JT, Silverberg SJ, Mendez AJ, Dong C, Wright CB, Wolf M (2016) Fibroblast growth factor 23 and cause-specific mortality in the general population: the northern Manhattan study. J Clin Endocrinol Metab 101:3779\u20133786","journal-title":"J Clin Endocrinol Metab"},{"key":"4598_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5414\/CN108407","volume":"82","author":"F Lima","year":"2014","unstructured":"Lima F, El-Husseini A, Monier-Faugere MC, David V, Mawad H, Quarles D, Malluche HH (2014) FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis. Clin Nephrol 82:287\u2013295","journal-title":"Clin Nephrol"},{"key":"4598_CR18","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s00198-011-1838-0","volume":"23","author":"L Desjardins","year":"2012","unstructured":"Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA, European Uremic Toxin Work G (2012) FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 23:2017\u20132025","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"4598_CR19","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00198-009-1142-4","volume":"21","author":"P Manghat","year":"2010","unstructured":"Manghat P, Fraser WD, Wierzbicki AS, Fogelman I, Goldsmith DJ, Hampson G (2010) Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 21:1853\u20131861","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"4598_CR20","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/jbmr.1985","volume":"28","author":"NE Lane","year":"2013","unstructured":"Lane NE, Parimi N, Corr M, Yao W, Cauley JA, Nielson CM, Ix JH, Kado D, Orwoll E, Osteoporotic Fractures in Men Study G (2013) Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic Fractures in Men (MrOS) study. J Bone Miner Res 28:2325\u20132332","journal-title":"J Bone Miner Res"},{"key":"4598_CR21","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1210\/jc.2013-1152","volume":"98","author":"A Jovanovich","year":"2013","unstructured":"Jovanovich A, Buzkova P, Chonchol M et al (2013) Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. J Clin Endocrinol Metab 98:3323\u20133331","journal-title":"J Clin Endocrinol Metab"},{"key":"4598_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40620-016-0284-7","volume":"29","author":"K Wei","year":"2016","unstructured":"Wei K, Yin Z, Xie Y (2016) Roles of the kidney in the formation, remodeling and repair of bone. J Nephrol 29:349\u2013357","journal-title":"J Nephrol"},{"key":"4598_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H et al (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45\u201351","journal-title":"Nature"},{"key":"4598_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bone.2013.08.008","volume":"57","author":"M Sasaki","year":"2013","unstructured":"Sasaki M, Hasegawa T, Yamada T, Hongo H, de Freitas PHL, Suzuki R, Yamamoto T, Tabata C, Toyosawa S, Yamamoto T, Oda K, Li M, Inoue N, Amizuka N (2013) Altered distribution of bone matrix proteins and defective bone mineralization in klotho-deficient mice. Bone 57:206\u2013219","journal-title":"Bone"},{"key":"4598_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bone.2016.11.025","volume":"100","author":"JM Hum","year":"2017","unstructured":"Hum JM, O'Bryan L, Smith RC, White KE (2017) Novel functions of circulating klotho. Bone 100:36\u201340","journal-title":"Bone"},{"key":"4598_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00198-016-3770-9","volume":"28","author":"M Atteritano","year":"2017","unstructured":"Atteritano M, Di Mauro E, Canale V, Bruzzese AM, Ricciardi CA, Cernaro V, Lacquaniti A, Buemi M, Santoro D (2017) Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 28:577\u2013584","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"4598_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","volume":"47","author":"MD Danese","year":"2006","unstructured":"Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM (2006) PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation 47:149\u2013156","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"4598_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11657-015-0217-4","volume":"10","author":"B Heidari","year":"2015","unstructured":"Heidari B, Hosseini R, Javadian Y, Bijani A, Sateri MH, Nouroddini HG (2015) Factors affecting bone mineral density in postmenopausal women. Arch Osteoporos 10:15","journal-title":"Arch Osteoporos"},{"key":"4598_CR29","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1007\/s00198-013-2363-0","volume":"24","author":"BJ Kim","year":"2013","unstructured":"Kim BJ, Lee SH, Koh JM, Kim GS (2013) The association between higher serum ferritin level and lower bone mineral density is prominent in women >\/=45 years of age (KNHANES 2008-2010). Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 24:2627\u20132637","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"4598_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2015.290","volume":"89","author":"V David","year":"2016","unstructured":"David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M (2016) Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 89:135\u2013146","journal-title":"Kidney Int"},{"key":"4598_CR31","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/hy1001.096358","volume":"38","author":"JGA Blacher","year":"2001","unstructured":"Blacher JGA, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938\u2013942","journal-title":"Hypertension"},{"key":"4598_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000438852","volume":"3","author":"C Fortier","year":"2016","unstructured":"Fortier C, Agharazii M (2016) Arterial Stiffness Gradient. Pulse (Basel) 3:159\u2013166","journal-title":"Pulse (Basel)"},{"issue":"69","key":"4598_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/HYPERTENSIONAHA.116.08409","volume":"1979","author":"C Fortier","year":"2017","unstructured":"Fortier C, Sidibe A, Desjardins MP, Marquis K, De Serres SA, Mac-Way F, Agharazii M (2017) Aortic-brachial pulse wave velocity ratio: a blood pressure-independent index of vascular aging. Hypertension Dallas Tex 1979(69):96\u2013101","journal-title":"Hypertension Dallas Tex"},{"key":"4598_CR34","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1210\/jc.2017-00104","volume":"102","author":"C Marcais","year":"2017","unstructured":"Marcais C, Maucort-Boulch D, Drai J et al (2017) Circulating klotho associates with cardiovascular morbidity and mortality during hemodialysis. J Clin Endocrinol Metab 102:3154\u20133161","journal-title":"J Clin Endocrinol Metab"},{"key":"4598_CR35","doi-asserted-by":"publisher","first-page":"e56695","DOI":"10.1371\/journal.pone.0056695","volume":"8","author":"M Kitagawa","year":"2013","unstructured":"Kitagawa M, Sugiyama H, Morinaga H, Inoue T, Takiue K, Ogawa A, Yamanari T, Kikumoto Y, Uchida HA, Kitamura S, Maeshima Y, Nakamura K, Ito H, Makino H (2013) A decreased level of serum soluble klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PLoS One 8:e56695","journal-title":"PLoS One"},{"key":"4598_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, Moe OW (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol : JASN 22:124\u2013136","journal-title":"J Am Soc Nephrol : JASN"},{"key":"4598_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12882-018-0851-3","volume":"19","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Kang E, Oh YK, Kim YH, Han SH, Yoo TH, Chae DW, Lee J, Ahn C, Oh KH (2018) The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study. BMC Nephrol 19:51","journal-title":"BMC Nephrol"},{"key":"4598_CR38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2217\/bmm-2016-0031","volume":"10","author":"S Jin","year":"2016","unstructured":"Jin S, Zhu M, Yan J, Fang Y, Lu R, Zhang W, Zhang Q, Lu J, Qi C, Shao X, Zhang H, Jiang R, Ni Z (2016) Serum sclerostin level might be a potential biomarker for arterial stiffness in prevalent hemodialysis patients. Biomark Med 10:689\u2013699","journal-title":"Biomark Med"},{"key":"4598_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12882-017-0705-4","volume":"18","author":"R Krishnasamy","year":"2017","unstructured":"Krishnasamy R, Tan SJ, Hawley CM, Johnson DW, Stanton T, Lee K, Mudge DW, Campbell S, Elder GJ, Toussaint ND, Isbel NM (2017) Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD. BMC Nephrol 18:281","journal-title":"BMC Nephrol"},{"key":"4598_CR40","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/ndt\/gft236","volume":"28","author":"Heijboer AC, Blankenstein MA, Hoenderop J, de Borst MH, Vervloet MG, consortium N","year":"2013","unstructured":"Heijboer AC, Blankenstein MA, Hoenderop J, de Borst MH, Vervloet MG, consortium N (2013) Laboratory aspects of circulating alpha-klotho. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 28:2283\u20132287","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"4598_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s00223-015-0105-3","volume":"98","author":"I Piec","year":"2016","unstructured":"Piec I, Washbourne C, Tang J, Fisher E, Greeves J, Jackson S, Fraser WD (2016) How accurate is your Sclerostin measurement? Comparison between three commercially available Sclerostin ELISA kits. Calcif Tissue Int 98:546\u2013555","journal-title":"Calcif Tissue Int"},{"key":"4598_CR42","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2215\/CJN.10941013","volume":"9","author":"ER Smith","year":"2014","unstructured":"Smith ER (2014) The use of fibroblast growth factor 23 testing in patients with kidney disease. Clin J Am Soc Nephrol : CJASN 9:1283\u20131303","journal-title":"Clin J Am Soc Nephrol : CJASN"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4598-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4598-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4598-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T03:05:35Z","timestamp":1569380735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4598-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,29]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["4598"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4598-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,29]]},"assertion":[{"value":"28 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}